查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612180

动物用药品市场：按类型、给药途径、应用和最终用户分类 - 全球预测 2025-2030

Animal Pharmaceuticals Market by Type (Vaccine, Veterinary Drugs), Route of Administration (Injectable, Oral, Topical), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年动物用药品市值为580.7亿美元，预计2024年将达到629.9亿美元，复合年增长率为8.61%，到2030年将达到1035.7亿美元。

动物用药品市场包括专门为动物（包括牲畜、宠物和野生动物）的健康和福祉而设计的产品。这个市场包括疫苗、抗生素、抗寄生虫药物和药物饲料添加剂等多种产品。对畜牧产品的需求不断增长、宠物饲养量的增加以及控制通用感染疾病的需要加剧了对动物用药品的需求。主要用途包括动物疾病预防、治疗和促进生长，对食品安全、公共卫生和消费者安全有直接影响。最终使用领域包括兽医医院、农场、宠物医院和动物研究所。成长要素包括畜牧业生产集约化、宠物旅行快速成长、技术进步、动物疾病发生率增加。机会包括新型高效药物的开发、药物输送系统的创新以及对天然和有机畜牧产品日益增长的偏好。随着消费者需求倾向于永续和健康意识的解决方案，鼓励公司专注于生物製药和食品。挑战包括严格的监管标准、不断上升的研发成本以及抗药性菌株的出现，这可能会阻碍市场扩张。此外，有关动物福利和抗生素过度使用的伦理问题也构成了主要障碍。需要创新的领域包括开发益生菌和益生元等抗生素替代品、增强疫苗功效以及利用资料分析进行个人化动物保健。专注于兽医远端医疗和人工智慧疾病诊断工具等数位医疗解决方案也可以推动业务成长。市场竞争激烈，监管压力不断变化，需要不断创新来应对不断变化的兽医健康挑战，而且市场很复杂，需要战略灵活性和持续的研究投资。

主要市场统计
基准年[2023] 580.7亿美元
预测年份 [2024] 629.9亿美元
预测年份 [2030] 1035.7亿美元
复合年增长率（%） 8.61%

市场动态：揭示快速发展的动物用药品市场的关键市场洞察

供需的动态交互作用正在改变动物用药品市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于通用感染疾病和慢性病的增加，宠物拥有量增加
    • 牲畜显着增加
    • 政府强制管理药物和疫苗接种
  • 市场限制因素
    • 由于宠物饲主的认知和教育有限，动物用药品高成本
  • 市场机会
    • 对有机和天然动物用药品的需求不断增长
    • 针对个别动物的精准医疗日益兴起
  • 市场挑战
    • 由于畜牧农民过度使用抗生素，人们越来越担心抗生素抗药性

波特五力：驾驭动物用药品市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解动物用药品市场的外部影响

外部宏观环境因素对动物用药品市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解动物用药品市场竞争状况

动物用药品市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵动物用药品市场供应商的绩效评估

FPNV定位矩阵是评估动物用药品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议描绘动物用药品市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对动物用药品市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 宠物数量增加，通用和感染疾病增加
      • 牲畜存栏量大幅增加
      • 政府强制用药和疫苗接种的出现
    • 抑制因素
      • 动物用药品成本高昂，宠物饲主的认知与教育有限
    • 机会
      • 对有机和天然动物用药品的需求不断增长
      • 针对个别动物的精准医疗不断涌现
    • 任务
      • 由于动物养殖场过度使用抗生素，人们越来越担心抗生素抗药性
  • 市场区隔分析
    • 类型：增加紧急治疗所需的动物用药品使用
    • 最终用户：推动兽医诊所动物用药品的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章动物用药品市场：依类型

  • 疫苗
    • 惰性（杀死）
    • 修復/衰减实时
  • 动物用药品
    • 止痛药
    • 抗感染
    • 发炎（药
    • 寄生剂

第七章动物用药品市场：依管理途径

  • 可注射的
  • 口服
  • 话题

第八章动物用药品市场：依用途

  • 水生动物
  • 伴同性动物
  • 家畜

第九章动物用药品市场：依最终用户分类

  • 医院
  • 研究所
  • 兽医诊所

第10章：美洲动物用药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太动物用药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲动物用药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Zoetis 在美国推出 BoncatPregabalin口服溶液，加强猫咪护理
    • Zoetis 和 Blacksmith Medicines 合作开发新型抗生素来对抗抗药性细菌并改善动物健康
    • 默克策略收购Elanco海鲜业务以加强其水产养殖部门
  • 战略分析和建议

公司名单

  • Alivira Animal Health Limited
  • Aurora Pharmaceutical, Inc.
  • Bimeda Holdings PLC
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Neogen Corp.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Norbrook Laboratories
  • Nutreco NV
  • Orion Corporation
  • Ourofino Saude Animal
  • Perrigo Company plc
  • PetIQ, LLC
  • Phibro Animal Health Corporation
  • Precision Science
  • Sanofi-Aventis Groupe SA
  • Vesper Group
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-434CCDA05128

The Animal Pharmaceuticals Market was valued at USD 58.07 billion in 2023, expected to reach USD 62.99 billion in 2024, and is projected to grow at a CAGR of 8.61%, to USD 103.57 billion by 2030.

The animal pharmaceuticals market encompasses products designed specifically for the health and well-being of animals, including livestock, pets, and wildlife. This market covers a range of products such as vaccines, antibiotics, antiparasitics, and medicinal feed additives. The necessity of animal pharmaceuticals is underscored by the rising demand for livestock products, increased pet ownership, and the need to manage zoonotic diseases. Key applications include disease prevention, treatment, and growth promotion in animals, which directly impacts food security, public health, and consumer safety. End-use sectors span veterinary clinics, animal farms, pet hospitals, and animal research institutes. Influencing growth factors include the intensification of livestock production, the surge in pet companionship, technological advancements, and increasing incidences of animal disease outbreaks. Opportunities emerge from the development of novel and efficient drugs, innovations in drug delivery systems, and the growing preference for natural and organic animal products. Companies are advised to focus on biopharmaceuticals and nutraceuticals, as consumer demand leans toward sustainable and health-conscious solutions. Challenges include stringent regulatory standards, high R&D costs, and the emergence of drug-resistant strains, which can inhibit market expansion. Additionally, ethical concerns regarding animal welfare and the overuse of antibiotics present significant hurdles. Areas ripe for innovation include the development of alternatives to antibiotics, such as probiotics and prebiotics, enhancing vaccine efficacy, and leveraging data analytics for personalized animal healthcare. Emphasizing digital healthcare solutions like telemedicine for animals and AI-driven disease diagnosis tools can also propel business growth. The market is competitive and dynamic, driven by regulatory pressures and the necessity for constant innovation to address evolving animal health challenges, signifying a complex landscape that necessitates strategic agility and continuous research investments.

KEY MARKET STATISTICS
Base Year [2023] USD 58.07 billion
Estimated Year [2024] USD 62.99 billion
Forecast Year [2030] USD 103.57 billion
CAGR (%) 8.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Pharmaceuticals Market

The Animal Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
    • Significant growth experienced in livestock population
    • Emergence of government mandatory medication and vaccinations
  • Market Restraints
    • High costs of animal pharmaceuticals along with limited awareness and education among pet owners
  • Market Opportunities
    • Growing demand for organic and natural animal pharmaceuticals
    • Increasing emergence of the precision medicine tailored for individual animals
  • Market Challenges
    • Increasing concern over antibiotic resistance due to overuse in animal farms

Porter's Five Forces: A Strategic Tool for Navigating the Animal Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Pharmaceuticals Market

A detailed market share analysis in the Animal Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Pharmaceuticals Market

A strategic analysis of the Animal Pharmaceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Alivira Animal Health Limited, Aurora Pharmaceutical, Inc., Bimeda Holdings PLC, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, Huvepharma, Inc., IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corp., Nippon Zenyaku Kogyo Co., Ltd., Norbrook Laboratories, Nutreco N.V., Orion Corporation, Ourofino Saude Animal, Perrigo Company plc, PetIQ, LLC, Phibro Animal Health Corporation, Precision Science, Sanofi-Aventis Groupe S.A., Vesper Group, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Vaccine and Veterinary Drugs. The Vaccine is further studied across Inactivated (Killed) and Modified/ Attenuated Live. The Veterinary Drugs is further studied across Analgesics, Anti-infectives, Anti-inflammatory, and Parasiticides.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Application, market is studied across Aquatic Animals, Companion Animals, and Livestock Animals.
  • Based on End User, market is studied across Hospitals, Laboratories, and Veternary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
      • 5.1.1.2. Significant growth experienced in livestock population
      • 5.1.1.3. Emergence of government mandatory medication and vaccinations
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of animal pharmaceuticals along with limited awareness and education among pet owners
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for organic and natural animal pharmaceuticals
      • 5.1.3.2. Increasing emergence of the precision medicine tailored for individual animals
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing concern over antibiotic resistance due to overuse in animal farms
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing usage of veterinary drugs indispensable for acute treatments
    • 5.2.2. End User: Evolving usage of the animal pharmaceuticals across the veterinary clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Pharmaceuticals Market, by Type

  • 6.1. Introduction
  • 6.2. Vaccine
    • 6.2.1. Inactivated (Killed)
    • 6.2.2. Modified/ Attenuated Live
  • 6.3. Veterinary Drugs
    • 6.3.1. Analgesics
    • 6.3.2. Anti-infectives
    • 6.3.3. Anti-inflammatory
    • 6.3.4. Parasiticides

7. Animal Pharmaceuticals Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Animal Pharmaceuticals Market, by Application

  • 8.1. Introduction
  • 8.2. Aquatic Animals
  • 8.3. Companion Animals
  • 8.4. Livestock Animals

9. Animal Pharmaceuticals Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Laboratories
  • 9.4. Veternary Clinics

10. Americas Animal Pharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Animal Pharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Animal Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Zoetis Enhances Feline Care with U.S. Launch of Bonqat Pregabalin Oral Solution
    • 13.3.2. Zoetis and Blacksmith Medicines Collaborate on Novel Antibiotics to Combat Resistant Bacteria and Enhance Animal Health
    • 13.3.3. Merck & Co. Bolsters Aquaculture Segment with Strategic Acquisition of Elanco's Aqua Business
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alivira Animal Health Limited
  • 2. Aurora Pharmaceutical, Inc.
  • 3. Bimeda Holdings PLC
  • 4. Boehringer Ingelheim International GmbH
  • 5. Ceva Sante Animale
  • 6. Dechra Pharmaceuticals PLC
  • 7. Elanco Animal Health Incorporated
  • 8. Hester Biosciences Limited
  • 9. Huvepharma, Inc.
  • 10. IDEXX Laboratories, Inc.
  • 11. Indian Immunologicals Ltd.
  • 12. Merck & Co., Inc.
  • 13. Neogen Corp.
  • 14. Nippon Zenyaku Kogyo Co., Ltd.
  • 15. Norbrook Laboratories
  • 16. Nutreco N.V.
  • 17. Orion Corporation
  • 18. Ourofino Saude Animal
  • 19. Perrigo Company plc
  • 20. PetIQ, LLC
  • 21. Phibro Animal Health Corporation
  • 22. Precision Science
  • 23. Sanofi-Aventis Groupe S.A.
  • 24. Vesper Group
  • 25. Vetoquinol S.A.
  • 26. Virbac S.A.
  • 27. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INACTIVATED (KILLED), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY MODIFIED/ ATTENUATED LIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023